Price History & Performance
|Historical stock prices|
|Current Share Price||ج.م1.80|
|52 Week High||ج.م1.25|
|52 Week Low||ج.م3.99|
|1 Month Change||0.11%|
|3 Month Change||-18.55%|
|1 Year Change||26.67%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||137.86%|
Recent News & Updates
|SPMD||EG Healthcare||EG Market|
Return vs Industry: SPMD exceeded the EG Healthcare industry which returned -16.1% over the past year.
Return vs Market: SPMD exceeded the EG Market which returned 9.2% over the past year.
Stable Share Price: SPMD is not significantly more volatile than the rest of EG stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: SPMD's weekly volatility (8%) has been stable over the past year.
About the Company
Speed Med S A E is based in Egypt.
Speed Medical Fundamentals Summary
|SPMD fundamental statistics|
Is SPMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SPMD income statement (TTM)|
|Cost of Revenue||ج.م33.52m|
Last Reported Earnings
Dec 31, 2018
Next Earnings Date
|Earnings per share (EPS)||0|
|Net Profit Margin||0.00%|
How did SPMD perform over the long term?See historical performance and comparison
Is Speed Medical undervalued compared to its fair value and its price relative to the market?
Share Price vs. Fair Value
Below Fair Value: SPMD (EGP1.8) is trading above our estimate of fair value (EGP1.68)
Significantly Below Fair Value: SPMD is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: Insufficient data to calculate SPMD's PE Ratio to determine if it is good value compared to the African Healthcare industry average.
PE vs Market: Insufficient data to calculate SPMD's PE Ratio to determine if it is good value compared to the EG market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SPMD's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: Insufficient data to calculate SPMD's PB Ratio to determine if it is good value.
How is Speed Medical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Speed Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Speed Medical performed over the past 5 years?
Historical Healthcare annual earnings growth
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Speed Medical has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
How is Speed Medical's financial position?
In this section we usually analyse Speed Medical's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Speed Medical has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
What is Speed Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SPMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SPMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SPMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SPMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SPMD's dividend in 3 years as they are not forecast to pay a notable one for the EG market.
How experienced are the management team and are they aligned to shareholders interests?
Speed Medical has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.
Speed Medical Company's employee growth, exchange listings and data sources
- Name: Speed Medical Company
- Ticker: SPMD
- Exchange: CASE
- Founded: NaN
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: ج.م1.996b
- Shares outstanding: 1.11b
- Speed Medical Company
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/21 14:32|
|End of Day Share Price||2021/10/20 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.